Henry Schein Inc. HSIC said Monday that it has authorized a new $400 million share repurchase program. Based on Friday’s closing price for the medical product company’s stock, the new buyback program represents 3.4% of the company’s market capitalization of $11.67 billion. The company said the new program is in addition to the $400 million program announced in August 2022, which is expected to be completed by the end of the first quarter.
... Henry Schein Inc. HSIC said Monday that it has authorized a new $400 million share repurchase program. Based on Friday’s closing price for the medical product company’s stock, the new buyback program represents 3.4% of the company’s market capitalization of $11.67 billion. The company said the new program is in addition to the $400 million program announced in August 2022, which is expected to be completed by the end of the first quarter.